TriReme Medical

TriReme Medical

Novel stent technologies for the treatment of coronary artery bifurcations.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor investor investor investor

€0.0

round

$18.0m

Series E
Total Funding000k
Notes (0)
More about TriReme Medical
Made with AI
Edit

TriReme Medical, a subsidiary of QT Vascular, specializes in the development and distribution of advanced angioplasty balloons, including the Chocolate and Glider families. These products are designed for the minimally invasive treatment of vascular diseases, offering an alternative to traditional stents which can lead to complications such as scar tissue buildup, metal fatigue, and the need for long-term blood thinning medications. The company serves healthcare providers and patients globally, operating in the medical device market with a focus on vascular health. TriReme Medical generates revenue through the sale of its innovative medical devices, which are designed to improve patient outcomes and reduce the long-term costs associated with vascular treatments.

Keywords: angioplasty balloons, vascular disease, minimally invasive, medical devices, stent alternatives, healthcare, global market, patient outcomes, innovation, QT Vascular.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo